Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Berger

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of the Neurological Sciences|April 3, 2020
Absent well-characterized onconeural antibodies in 283 patients with various polyneuropathies: A retrospective monocenter studyBenjamin Berger, Alexander Jürgen Klingler, Sebastian Rauer, et al.
Journal of Clinical Pharmacology|May 27, 2024
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3AMassimo Magliocca, Benjamin Berger, Vincent Lemoine, et al.
Toxicology|July 30, 2015
Impaired mitochondrial function in HepG2 cells treated with hydroxy-cobalamin[c-lactam]: A cell model for idiosyncratic toxicityPatrizia Haegler, David Grünig, Benjamin Berger, et al.
Frontiers in Pharmacology|August 9, 2018
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe DrugBenjamin Berger, Fabio Bachmann, Urs Duthaler, et al.
International Journal of Pharmaceutics|August 28, 2016
CombiCap: A novel drug formulation for the basel phenotyping cocktailMarine Camblin, Benjamin Berger, Manuel Haschke, et al.
Journal of the Neurological Sciences|April 1, 2015
"Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expectedBenjamin Berger, Patricia Bischler, Rick Dersch, et al.
Journal of the Neurological Sciences|December 28, 2020
Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric studyJuliane Weber, Nora Bernsdorff, Tilman Robinson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Fluids and Barriers of the CNS|February 8, 2017
The MRZ reaction in primary progressive multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.
Plos One|January 31, 2017
Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in MicePatrizia Haegler, David Grünig, Benjamin Berger, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of the Neurological Sciences|April 3, 2020
Absent well-characterized onconeural antibodies in 283 patients with various polyneuropathies: A retrospective monocenter studyBenjamin Berger, Alexander Jürgen Klingler, Sebastian Rauer, et al.
Journal of Clinical Pharmacology|May 27, 2024
Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3AMassimo Magliocca, Benjamin Berger, Vincent Lemoine, et al.
Toxicology|July 30, 2015
Impaired mitochondrial function in HepG2 cells treated with hydroxy-cobalamin[c-lactam]: A cell model for idiosyncratic toxicityPatrizia Haegler, David Grünig, Benjamin Berger, et al.
Frontiers in Pharmacology|August 9, 2018
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe DrugBenjamin Berger, Fabio Bachmann, Urs Duthaler, et al.
International Journal of Pharmaceutics|August 28, 2016
CombiCap: A novel drug formulation for the basel phenotyping cocktailMarine Camblin, Benjamin Berger, Manuel Haschke, et al.
Journal of the Neurological Sciences|April 1, 2015
"Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expectedBenjamin Berger, Patricia Bischler, Rick Dersch, et al.
Journal of the Neurological Sciences|December 28, 2020
Diagnosis of multiple sclerosis in times of MOG and AQP4 autoantibody testing - A monocentric studyJuliane Weber, Nora Bernsdorff, Tilman Robinson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2020
COVID-19 pneumonia in a multiple sclerosis patient with severe lymphopenia due to recent cladribine treatmentRick Dersch, Thomas Wehrum, Sebastian Fähndrich, et al.
Fluids and Barriers of the CNS|February 8, 2017
The MRZ reaction in primary progressive multiple sclerosisTilman Hottenrott, Rick Dersch, Benjamin Berger, et al.
Plos One|January 31, 2017
Hepatic Effects of Pharmacological Doses of Hydroxy-Cobalamin[c-lactam] in MicePatrizia Haegler, David Grünig, Benjamin Berger, et al.
Pageof 7